LeptiCore Composition Reducing Body Fat and Metabolic Biomarkers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for metabolic syndrome, particularly those targeting individual components, face challenges such as safety concerns, high costs, and the complexity of the condition, while also failing to adequately address oxidative stress and leptin resistance, which contribute to weight gain and obesity.
Innovation Solution
A composition called LeptiCore, comprising plant-based polysaccharides, esterified fatty acids, pomegranate polyphenols, ellagic acid, and Aphanizomenon flos-aquae extract, which reduces body fat, enhances weight loss, acts as an antioxidant, and ameliorates metabolic syndrome symptoms by lowering leptin levels and reducing C-reactive protein, thereby improving leptin signaling and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmacological agents targeting individual components of metabolic syndrome are used, then specific symptoms can be treated, but safety concerns and high costs increase
Solution Approach 1:
The patent combines multiple plant-based ingredients with different mechanisms of action into a single composition (LeptiCore®) that addresses multiple components of metabolic syndrome simultaneously. This includes ingredients that reduce oxidative stress, improve insulin sensitivity, regulate leptin levels, and reduce inflammation, thereby treating the syndrome holistically while avoiding the safety and cost issues of multiple separate pharmacological agents
Solution Approach 2:
The patent uses plant-based ingredients and natural compounds as alternatives to expensive pharmacological agents. These natural ingredients provide therapeutic effects at lower cost and with better safety profiles, replacing costly medications with affordable natural supplements
2Reliability
If current treatments for metabolic syndrome are used, then some symptoms are addressed, but oxidative stress and leptin resistance are not adequately addressed
Solution Approach 1:
The patent converts the harmful effects of oxidative stress and leptin resistance into beneficial outcomes by using ingredients that specifically target these mechanisms. Antioxidant ingredients neutralize oxidative stress, while ingredients that regulate leptin levels and reduce CRP convert the harmful leptin resistance state into effective leptin signaling, thereby addressing the root causes rather than just symptoms
Solution Approach 2:
The patent introduces plant-based ingredients as intermediaries that mediate between the harmful states (oxidative stress, leptin resistance) and healthy physiological function. These ingredients act as mediators that reduce CRP levels, improve leptin sensitivity, and eliminate oxidative stress, thereby restoring normal metabolic function
Data Source
AI summary
The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.